Key result
Left atrial assessment tracks HCM progression beyond sudden cardiac death risk.
Answers are grounded in this paper and cite their sources.
Should not yet change hypertrophic cardiomyopathy practice; leaves open the need for prospective validation of left atrial metrics.
Andrea Faggiano, Guillem Casas, José F Rodríguez Palomares, Stefano Carugo; Beyond sudden cardiac death: the left atrium as a window into disease progressi
No takes yet. Share an insight, caveat, or question.
Faggiano et al. (2026) studied this question. Left atrial assessment serves as a key indicator of disease progression in hypertrophic cardiomyopathy, extending beyond the traditional focus on sudden cardiac death risk.
Synapse has enriched 10 related papers. Consider them for comparative context: